Tag Archives: FDA panel debates Pfizer’s COVID-19 shot for school-age kids on Tuesday; here’s what to know

Vaccine experts, in a public meeting Tuesday, will weigh the safety and benefits of Pfizer’s COVID-19 vaccine for school-age children. Based on the independent panel’s recommendations, the Food and Drug Administration and the Centers for Disease Control and Prevention could authorize the shot for the nation’s 28 million children ages 5 to 11 by next week, with smaller needles and a …

Read More »